Breaking News: Luminous Labs Secures $500K Funding for Cutting-Edge CellLight™ Technology

Luminous Labs is thrilled to announce that we have successfully raised €500,000 in our latest funding round, marking a significant milestone in our journey towards revolutionizing health and longevity. Founded in 2021 by dedicated PhD students and life partners, Babsi and Thomas, Luminous Labs is at the forefront of biohacking innovation, harnessing the transformative power of light to supercharge cellular performance. Our flagship product, CellLight™, is scientifically designed to enhance the human healthspan, enabling users to look, feel, and perform better through targeted light therapy. The newly acquired funds will play a crucial role in advancing our research and development efforts, allowing us to refine our technology and expand our product offerings. We are also excited to invest in marketing initiatives aimed at reaching a global audience, ensuring that more individuals can experience the benefits of our groundbreaking approach to health. Based in Graz, Austria, we are dedicated to our mission of ending aging or die trying, and we believe that our innovation can truly make a difference in people's lives. As we embark on this next chapter, we are grateful for the support of our investors and look forward to sharing the powerful impact of our CellLight™ technology with the world. Stay tuned for more updates as we continue to push the boundaries of health and longevity, one light-filled cell at a time!